← Back to Patent Explorer
US3966978A Expired / Lapsed US ⏱️ 0.0 years remaining

4-Biphenylacetic acid as an inhibitor of platelet aggregation

Assignee: Wyeth Holdings LLC
•
Filing: 1975-04-25
•
Granted: 1976-06-29
•
Expires: 1995-04-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The use of 4-biphenylacetic acid in the amelioration of blood platelet aggregation.

Inventors

  • 👤 Leon Ellenbogen
  • 👤 Constance Anne Kohler

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 13:15
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 34 words
A method of producing an inhibitory effect on blood platelet aggregation which comprises incorporating into the blood of a thrombotic warm-blooded animal an effective amount of 4-biphenylacetic acid or a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim 34 words
A method of producing an inhibitory effect on blood platelet aggregation which comprises incorporating into the blood of a thrombotic warm-blooded animal an effective amount of 4-biphenylacetic acid or a pharmaceutically acceptable salt thereof.
Claim 3
Independent Claim 34 words
A method of ameliorating thrombotic conditions in a warm-blooded animal associated with blood platelet aggregation, which comprises internally administering to said animal an effective amount of 4-biphenylacetic acid or a pharmaceutically acceptable salt thereof.
Claim 4
Independent Claim 34 words
A method of ameliorating thrombotic conditions in a warm-blooded animal associated with blood platelet aggregation, which comprises internally administering to said animal an effective amount of 4-biphenylacetic acid or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 11 words
A method according to claim 2 wherein said administration is orally.
Claim 6
Dependent Claim 30 words
A method according to claim 3 wherein 4-biphenylacetic acid is administered to provide a daily dosage of from about 0.5 to about 250 mg./kg./day of body weight of said animal.

References Cited (Backward Citations)

US3784704A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-06-29 1979-12-29 1980-06-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-06-29 1983-12-29 1984-06-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-06-29 1987-12-29 1988-06-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag